Medesis Pharma SA (ALMDP) — Net Asset Quality Index
Medesis Pharma SA (ALMDP) has a Net Asset Quality Index of -242.0% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.11 Million minus total liabilities of €7.20 Million yields net assets of €-5.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Medesis Pharma SA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medesis Pharma SA Net Asset Quality Index Over Time (2018–2023)
This chart shows how Medesis Pharma SA's Net Asset Quality Index has evolved across 6 annual periods from 2018 to 2023. As of June 2024, the index stands at -242.0%, representing net assets of €-5.10 Million against total assets of €2.11 Million EUR. Explore Medesis Pharma SA (ALMDP) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Medesis Pharma SA (2018–2023)
The table below presents the year-by-year Net Asset Quality Index for Medesis Pharma SA from 2018 to 2023, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ALMDP market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | -233.6% | €-4.50 Million | €1.93 Million | €6.43 Million | ▼ -178.4 pp |
| 2022 | -55.2% | €-1.06 Million | €1.92 Million | €2.97 Million | ▼ -93.3 pp |
| 2021 | 38.0% | €1.65 Million | €4.33 Million | €2.68 Million | ▲ +286.6 pp |
| 2020 | -248.6% | €-2.08 Million | €837.91K | €2.92 Million | ▲ +90.1 pp |
| 2019 | -338.7% | €-2.42 Million | €714.00K | €3.13 Million | ▼ -284.7 pp |
| 2018 | -53.9% | €-876.00K | €1.62 Million | €2.50 Million | — |